Peter M Klein Selected Research

Peter M Klein Research Topics

8	Seizures (Absence Seizure) 01/2024 - 04/2011
3	Epilepsy (Aura) 01/2024 - 01/2012
3	Hypoxia (Hypoxemia) 03/2013 - 01/2012
1	Neuroinflammatory Diseases 01/2020
1	Mood Disorders (Mood Disorder) 01/2020
1	Glioblastoma (Glioblastoma Multiforme) 01/2020
1	Neoplasms (Cancer) 01/2020
1	Hyperaldosteronism (Conn Syndrome) 10/2016
1	Adenoma (Adenomas) 10/2016
1	Tuberous Sclerosis (Bourneville's Disease) 01/2012
1	Autistic Disorder (Autism) 01/2012

3	TOR Serine-Threonine KinasesIBA 11/2013 - 01/2012
2	Glutamate Receptors (Glutamate Receptor)IBA 01/2015 - 12/2012
2	Kainic Acid (Kainate)IBA 05/2014 - 12/2012
2	AMPA Receptors (AMPA Receptor)IBA 11/2013 - 03/2013
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2024
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2024
1	Serotonin (5 Hydroxytryptamine)IBA 01/2020
1	Serotonin ReceptorsIBA 01/2020
1	Temozolomide (Temodar)FDA LinkGeneric 01/2020
1	AldosteroneIBA 10/2016
1	N-Methylaspartate (NMDA)IBA 01/2015
1	Tyrosine Kinase InhibitorsIBA 05/2014
1	lestaurtinibIBA 05/2014
1	2,3- dioxo- 6- nitro- 7- sulfamoylbenzo(f)quinoxaline (NBQX)IBA 11/2013
1	Phosphotransferases (Kinase)IBA 03/2013
1	Anticonvulsants (Antiepileptic Drugs)IBA 03/2013
1	Serine (L-Serine)FDA Link 12/2012
1	AMPA 1 glutamate receptor ionotropicIBA 12/2012
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2012
1	Sirolimus (Rapamycin)FDA Link 01/2012
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2012
1	fluoro jadeIBA 04/2011
1	Phenobarbital (Luminal)FDA Link 04/2011